Corruption Risk: Responding to Critical Issues in the Pharmaceutical Industry

| 01 November 2010

As regulators and law enforcement officials in the US and abroad shine brighter spotlights on the pharmaceutical industry, it is more important than ever for life sciences companies to have programs to evaluate, mitigate and monitor corruption risk. A robust anti-corruption compliance program provides a critical "rule book" for life sciences companies conducting business in today's global economy.

 

© 2022 Regulatory Affairs Professionals Society.

Discover more of what matters to you

No taxonomy